Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer.

Papageorgiou, Georgios I; Fergadis, Evangelos; Skouteris, Nikos; Christakos, Evridiki; Tsakatikas, Sergios A; Lianos, Evangelos; Kosmas, Christos

Papageorgiou, Georgios I; Fergadis, Evangelos; Skouteris, Nikos; Christakos, Evridiki; Tsakatikas, Sergios A; Lianos, Evangelos; Kosmas, Christos.

Afiliação

Papageorgiou GI; Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, ''Metaxa'' Cancer Hospital, Piraeus, Greece.
Fergadis E; Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, ''Metaxa'' Cancer Hospital, Piraeus, Greece.
Skouteris N; Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, ''Metaxa'' Cancer Hospital, Piraeus, Greece.
Christakos E; Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, ''Metaxa'' Cancer Hospital, Piraeus, Greece.
Tsakatikas SA; Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, ''Metaxa'' Cancer Hospital, Piraeus, Greece.
Lianos E; Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, ''Metaxa'' Cancer Hospital, Piraeus, Greece.
Kosmas C; Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, ''Metaxa'' Cancer Hospital, Piraeus, Greece.

Front Oncol ; 11: 788809, 2021.

Article em En | MEDLINE | ID: mdl-35004311

Palavras-chave

ATM mutation; PARP inhibition; case report; colorectal cancer; targeted NGS

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia